Cornerstone Strategic Investment Fund Inc.

News & Events

Press Releases

In The Media

1. Cornerstone Funds Announce Continuing Monthly Distributions

   GlobeNewswire MAY 9, 2025 4:57 PM EDT
   NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Cornerstone Strategic Investment Fund, Inc. (NYSE Amer...
   READ ARTICLE

2. Cornerstone Strategic Investment Fund, Inc. Announces Rights Offering

   GlobeNewswire APR 10, 2025 4:30 PM EDT
   NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Cornerstone Strategic Investment Fund, Inc. (NYSE Am...
   READ ARTICLE

3. Cornerstone Total Return Fund, Inc. Announces Rights Offering

   GlobeNewswire APR 10, 2025 4:15 PM EDT
   NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Cornerstone Total Return Fund, Inc. (NYSE American: ...
   READ ARTICLE

4. Cornerstone Funds File Their Annual Reports

   GlobeNewswire MAR 4, 2025 4:45 PM EST
   NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Cornerstone Strategic Investment Fund, Inc. (NYSE Am...
   READ ARTICLE

5. Cornerstone Funds Announce Continuing Monthly Distributions

   GlobeNewswire FEB 7, 2025 4:30 PM EST
   NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Cornerstone Strategic Investment Fund, Inc. (NYSE Ame...
   READ ARTICLE

6. Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

   GlobeNewswire DEC 19, 2024 7:05 AM EST
   ALPHARETTA, Ga., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD)...
   READ ARTICLE

7. Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

   GlobeNewswire NOV 25, 2024 7:05 AM EST
   - Commercial, Clinical and Regulatory Expertise Establish Clearside as the Leader in Suprachoroid...
   READ ARTICLE

8. Cornerstone Strategic Value Fund, Inc. Announces Name Change

   GlobeNewswire NOV 22, 2024 4:15 PM EST
   NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) --  The Board of Directors of Cornerstone Strategic...
   READ ARTICLE

9. Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

   GlobeNewswire NOV 12, 2024 4:05 PM EST
   - Recent ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieved All Primary and Seco...
   READ ARTICLE

10. Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

    GlobeNewswire NOV 7, 2024 9:05 AM EST
    - Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye D...
    READ ARTICLE